The DOI matches its Crossref record.
Improvement of Coronary Flow Reserve After Long-term Therapy With Enalapril
Abstract
Abstract To date, no clinical study shows an improvement in coronary flow reserve due to long-term antihypertensive therapy. In view of the contribution of the renin-angiotensin system to the process of hypertensive remodeling of the heart and coronary circulation, angiotensin-converting enzyme (ACE) inhibitors might act as cardioreparative drugs in arterial hypertension. Accordingly, our objective in this investigation was to examine under clinical conditions to what extent long-term antihypertensive treatment with an angiotensin-converting enzyme inhibitor improved the diminished coronary flow reserve in hypertensive patients with microvascular angina pectoris. For the purpose of comparison, we also treated a normotensive control group of 6 patients with hypertrophic nonobstructive cardiomyopathy. Fifteen hypertensive individuals (10 men, 5 women; age, 58±6 years) were treated with enalapril (10 to 20 mg/d; mean, 16.7±4.9 mg/d) for 11 to 13 months. At the end of the treatment period, systolic pressure decreased from 178±14 to 137±12 mm Hg and diastolic pressure from 102±11 to 86±4 mm Hg under ambulatory conditions. Left ventricular muscle mass index decreased by 8%, from 149±32 to 137±28 g/m 2 ( P <.05). Maximal coronary blood flow after dipyridamole was increased by 43%, from 181±69 to 258±116 mL/min per 100 g ( P <.001), and minimal coronary vascular resistance was diminished by 29%, from 0.66±0.23 to 0.47±0.24 mm Hg·min·100 g·mL −1 ( P <.001) after enalapril treatment. Consequently, the calculated coronary reserve increased from 2.2±0.6 to 3.3±1.2 ( P <.001). After enalapril therapy, the functional class of angina pectoris according to the Canadian classification system had changed from 2.5±0.6 to 1.5±0.6 ( P <.01). The maximal working capacity had increased from 23.775±3.970 to 26.255±4.598 J (mean±SE, P <.05). The maximal ST-segment depression at maximal workload was reduced from 0.18±0.02 to 0.06±0.02 mV (mean±SE, P <.01). In summary, long-term therapy with the angiotensin-converting enzyme inhibitor enalapril must be considered a cardioreparative treatment with respect to the coronary microcirculation in hypertensive heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 616
Park, J. B., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00013 · Cited by 325
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis
Kelshiker, M. A., Seligman, H., Howard, J. P., Rahman, H., Foley, M., Nowbar, A. N., Rajkumar, C. A., Shun-Shin, M. J., Ahmad, Y., Sen, S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab775 · Cited by 311
Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies
Marinescu, M. A., Löffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.12.008 · Cited by 302
Vascular Remodeling in Hypertension: Mechanisms and Treatment
Schiffrin, E. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187021 · Cited by 276
Reduced Myocardial Flow Reserve in Non–Insulin-Dependent Diabetes Mellitus
Yokoyama, I., Momomura, S.-I., Ohtake, T., Yonekura, K., Nishikawa, J., Sasaki, Y., & Omata, M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00327-6 · Cited by 271
Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 253
Niskanen, L., Hedner, T., Hansson, L., Lanke, J., Niklason, A., & for the CAPPP study group (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2091 · Cited by 219
Kyriakidis, M., Triposkiadis, F., Dernellis, J., Androulakis, A. E., Mellas, P., Kelepeshis, G. A., & Gialafos, J. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1342 · Cited by 42
Metadata
- Authors
- Motz, W., & Strauer, B. E.
- Venue
- Hypertension
- Published
- 1996-05
- Volume
- 27
- Issue
- 5
- Pages
- 1031-1038
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2141681173
- Cited by
- 175
- References
- 0
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.